The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore model

被引:0
|
作者
Nikas S.P. [1 ]
Grzybowska J. [1 ]
Papahatjis D.P. [2 ]
Charalambous A. [1 ]
Banijamali A.R. [1 ,3 ]
Chari R. [1 ]
Fan P. [1 ]
Kourouli T. [2 ]
Lin S. [1 ]
Nitowski A.J. [3 ]
Marciniak G. [1 ]
Guo Y. [1 ]
Li X. [1 ]
Wang C.-L.J. [4 ]
Makriyannis A. [1 ]
机构
[1] Department of Pharmaceutical Sciences, Center for Drug Discovery, University of Connecticut, Storrs, CT 06269
[2] Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation, Athens 116-35
[3] Crompton Corp., Middlebury
[4] DuPont Merek Co., Wilmington
基金
美国国家卫生研究院;
关键词
CB1 cannabinoid receptors; Halogen substitution; Tetrahydrocannabinol;
D O I
10.1208/aapsj060430
中图分类号
学科分类号
摘要
The presence of halogens within the classical cannabinoid structure leads to large variations in the compounds' potencies and affinities for the CB1 receptors. To explore the structure activity relationships within this class of analogs we have used a series of halogen-substituted (-)-Δ8-tetrahydrocannabinol analogs and compared their affinities for the CB1 cannabinoid receptor. Our results indicate that halogen substitution at the end-carbon of the side chain leads to an enhancement in affinity with the bulkier halogens (Br, I) producing the largest effects. Conversely, 2-iodo substitution on the phenolic ring leads to a 2-fold reduction in affinity while iodo-substitution in the C1′-position of the side chain lowers the compound's affinity for CB1 by more than 8-fold. The pharmacophoric requirements resulting from halogen-substitution are explored using computer modeling methods. Copyright ©2003. All Rights Reserved.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] COMP 202-Virtual screening with pharmacophore model: Application in search of novel CB1 antagonists
    Wang, Hongwu
    Duffy, Ruth A.
    Boykow, George
    Chackalamannil, Samuel
    Madison, Vincent S.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [22] QSAR Model based on Molecular Descriptors Built to Predict the CB1 Binding Affinity of JWH Cannabinoids
    Rindunica , Madalina-Manuela
    Gosav, Steluta
    Praisler, Mirela
    Ion, Adelina
    2019 E-HEALTH AND BIOENGINEERING CONFERENCE (EHB), 2019,
  • [23] Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
    Davis, Mellar P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (08) : 1123 - 1140
  • [24] Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors
    Richardson, JD
    Kilo, S
    Hargreaves, KM
    PAIN, 1998, 75 (01) : 111 - 119
  • [25] Endogenous and synthetic cannabinoids induce the downregulation of cannabinoid CB1 receptor in retina
    Papadogkonaki, Sofia
    Theodorakis, Kostas
    Thermos, Kyriaki
    EXPERIMENTAL EYE RESEARCH, 2019, 185
  • [26] Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
    Gessa, G
    Melis, M
    Muntoni, A
    Diana, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 341 (01) : 39 - 44
  • [27] Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
    Talwar, Rashmi
    Potluri, Vijay Kumar
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (05) : 536 - 544
  • [28] The role of the CB1 receptor in the regulation of sleep
    Murillo-Rodriguez, Eric
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06): : 1420 - 1427
  • [29] An enquiry to the role of CB1 receptors in neurodegeneration
    Fernandez-Moncada, Ignacio
    Eraso-Pichot, Abel
    Dalla Tor, Tommaso
    Fortunato-Marsol, Berenice
    Marsicano, Giovanni
    NEUROBIOLOGY OF DISEASE, 2023, 184
  • [30] The role of CB1 receptors in psychostimulant addiction
    Wiskerke, Joost
    Pattij, Tommy
    Schoffelmeer, Anton N. M.
    De Vries, Taco J.
    ADDICTION BIOLOGY, 2008, 13 (02) : 225 - 238